@article{article, title  = {{Pertuzumab for the Neoadjuvant Treatment of Early-Stage HER2-Positive Breast Cancer: An Evidence Review Group Perspective of a NICE Single Technology Appraisal}},

 publisher = {{Springer Verlag }},

 url = {{https://eprints.whiterose.ac.uk/id/eprint/119850 }},

 year = {{2018}},

 month = {{1}},

 author = {{Squires H and Pandor A and Thokala P and Stevens JW and Kaltenthaler E and Clowes M and Coleman R and Wyld L}},

 doi = {{10.1007/s40273-017-0556-7}},

 volume = {{36}},

 journal = {{Pharmacoeconomics}},

 issue = {{1}},

 pages = {{29-38}},

 note = {{Accessed on 2025/10/31}}}